InsiderTrades

Form 4 for MRK Merck & Co.

Accepted 2026-05-01 18:32:27 ET · period of report 2026-04-29 · accession 0000310158-26-000097 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-05-01 18:32 2026-04-29 MRK Chattopadhyay Sanat Exe V-P, Pres. MMD M - OptEx $110.03 +2,597 16.5K +19% +$285.7K
D 2026-05-01 18:32 2026-04-29 MRK Chattopadhyay Sanat Exe V-P, Pres. MMD F - Tax $110.03 -1,130 15.3K -7% -$124.3K
D 2026-05-01 18:32 2026-04-29 MRK Chattopadhyay Sanat Exe V-P, Pres. MMD M - OptEx $0.00 -2,597 5,194 -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-04-29 M A 2,597 $110.03 16,477 D — —
2 Common Common Stock 2026-04-29 F D 1,130 $110.03 15,347 D — —
3 Derivative Restricted Stock Unit 2026-04-29 M D 2,597 $0.00 5,194 D — · 2026-04-29 to 2028-04-29 2,597 Common Stock (F4) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F5) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.